The Official Publication Of The Florida Pharmacy Association MAR. 2021
INTRODUCING THE PRESIDENT-ELECT OF THE AMERICAN PHARMACISTS ASSOCIATION :
THERESA TOLLE F P A CE LE BRA TE S W O ME N ’ S HIST OR Y MO N T H
IMPROVE
YOUR PHARMACY OPERATIONS • Minimize dispensing errors • Increase revenue and profitability • Automate workflow management • Customize analytics and reports
Pharmacy Management System
Schedule a DEMO today!
(866) 495-3999
sales@micromerchantsystems.com
www.micromerchantsystems.com
Web portals and apps for patients, physicians and owners Turnkey refill management and automation RxSync – sync all refills to one date Two-way SMS/text message from the patient’s profile Route optimization through Google Maps Customizable workflow capabilities for Specialty, Mail Order and other pharmacy configurations Clinical assessment module
florida PHARMACY TODAY Departments 4 Calendar 4 Advertisers 5 Executive Insight 6 Call for Resolutions 19 Call for Abstracts
VOL. 84 | NO. 3 MARCH 2021 THE OFFICIAL PUBLICATION OF THE FLORIDA PHARMACY ASSOCIATION
Features
8 10 11 12 18
2021 Legislative Session Update
Botulinum Toxin - from Poison to Remedy Former FPA President Theresa Tolle Elected to Lead the American Pharmacists Association HIV Treatments New Data Show Decline in Drug Overdose Deaths
The Florida Pharmacy Association Opposes Racism and Hatred in Society The Florida Pharmacy Association condemns all acts of racial discrimination and violence. Racism in any form has no place within our society or our profession, and the FPA does not tolerate such acts. We are dedicated to promoting inclusivity and diversity in a society that has no tolerance for racism or hate towards anyone. (FPA Board of Directors - March 21, 2021)
MARCH 2021
|
3
Mission Statements:
FPA Calendar 2020
APRIL 2
JULY
Good Friday, FPA office closed
17-18 FPA Regulatory and Law conference 30
Last day of the Legislative session MAY
9
5
FPA Office Closed for Independence Day
7-11
131st Annual FPA Meeting and Convention Ponte Vedra
Last day to submit resolutions to the House of Delegates
15-16 Clinical Conference 31
Memorial Day - FPA office Closed JUNE
8
Last day to submit items of new business to the House of Delegates
8
Last day to register for the House of Delegates summer session
Events calendar subject to change
CE CREDITS (CE cycle) The Florida Board of Pharmacy requires 10 hours’ LIVE continuing education as part of the required 30 hours’ general education needed every license renewal period. There is a two-hour CE requirement for pharmacists on the dispensing of controlled substances effective this biennial renewal period. Pharmacists and pharmacy technicians must also have completed a one-hour Florida Board approved continuing education on human trafficking by Jan. 1, 2021. Pharmacists should have satisfied all continuing education requirements for this biennial period by Sept. 30, 2021, or prior to licensure renewal. Consultant pharmacists and technicians will need to renew their licenses and registrations by Dec. 31, 2022. For the Pharmacy Technician Certification Board application, exam information and study materials, please contact the FPA office. For more information on CE programs or events, please contact the Florida Pharmacy Association at (850) 222-2400 or visit our website at www.floridapharmacy.org CONTACTS FSHP — Tamekia Bennett (850) 906-9333 UF — Emely McKitrick (352) 273-5169
FAMU — Leola Cleveland (850) 599-3301 NSU — Carsten Evans (954) 262-1300
The Florida Pharmacy Today Journal is a peer-reviewed journal which serves as a medium through which the Florida Pharmacy Association can communicate with the profession on advances in the sciences of pharmacy, socio-economic issues bearing on pharmacy and newsworthy items of interest to the profession. As a self-supported journal, it solicits and accepts advertising congruent with its expressed mission.
Florida Pharmacy Today Board of Directors
FOR A COMPLETE CALENDAR OF EVENTS GO TO WWW.FLORIDAPHARMACY.ORG
FPA — Michael Jackson (850) 222-2400
Florida Pharmacy Today Journal
Note: The views of the authors do not necessarily represent the views or opinions of the Florida Pharmacy Association, Florida Pharmacy Today or any related entities.
The mission of the Florida Pharmacy Today Board of Directors is to serve in an advisory capacity to the managing editor and executive editor of the Florida Pharmacy Today Journal in the establishment and interpretation of the Journal’s policies and the management of the Journal’s fiscal responsibilities. The Board of Directors also serves to motivate the Florida Pharmacy Association members to secure appropriate advertising to assist the Journal in its goal of self-support.
Advertisers APMS..................................................................... 7 EPIC..................................................................... 11 KAHAN............................................................... 11 MICRO MERCHANTS........................................ 2 PQC...................................................................... 20 PHARMACISTS MUTUAL.............................. 17 SAFE MEDICINES............................................... 9
DISCLAIMER Articles in this publication are designed to provide accurate and authoritative information with respect to the subject matter covered. This information is provided with the understanding that neither Florida Pharmacy Today nor the Florida Pharmacy Association is engaged in rendering legal or other professional services through this publication. If expert assistance or legal advice is required, the services of a competent professional should be sought. The use of all medications or other pharmaceutical products should be used according to the recommendations of the manufacturers. Information provided by the maker of the product should always be consulted before use.
4 |
FLORIDA PHARMACY TODAY
EMAIL YOUR SUGGESTIONS/IDEAS TO dave@fiorecommunications.com
Executive Insight BY MICHAEL JACKSON, RPH MICHAEL JACKSON, BPHARM, EVP & CEO, FLORIDA PHARMACY ASSOCIATION
A
History Continues to be Written in Florida
s we close out the month of March, let us remember that we have celebrated National Woman’s History Month. Many interesting events have occurred in pharmacy that we can revel in. Let’s start with the Florida Pharmacy Association. In the 134-year history of our organization, we have benefited from the leadership and wisdom of nine women who served as its president. It has been my honor to support eight of nine of these special elected leaders as your Executive Vice President and CEO. I am pleased to share with the members that Dr. Carol Motycka of Jacksonville will be installed as president-elect of the FPA at the annual meeting this summer in
In the 134-year history of our organization, we have benefited from the leadership and wisdom of nine women who served as its president.
Michael Jackson, B.Pharm
Ponte Vedra, Florida. She will be making history as our 10th woman president. It is fitting that we share this information with our members during this celebratory month of March. There is more to be recognized this month. To my knowledge, APhA had two Floridians elected and serving as its president since its inception. We all followed the efforts and work of Dr. Ed Hamilton from Lake Alfred, Florida. Ed gave many hours of his personal time in support of the Association’s mission as a servant leader with the FPA as its president. He followed that up with a tenure as APhA’s President and Chairman of the Board of Trustees. We are now pleased to report that Sebastian, Florida pharmacist and past FPA president Theresa Tolle has been installed as president-elect of the American Pharmacists Association. She will be the third Floridian to carry the torch for America’s pharmacists. You can read more about her in this journal. The history of pharmacy in our state is not written in a book with a beginning and an end. Chapters are added regularly, and the best stories are yet to be told. If any of our members has a desire to take on a greater role and make a difference in our profession, consider answering the call as a candidate for leadership. The road to service in our national associations begin with an apprenticeship within the Sunshine State. Get involved, make a difference and be a part of our ever-growing history. n
MARCH 2021
|
5
FPA STAFF Executive Vice President/CEO Michael Jackson (850) 222-2400, ext. 200
Director of Continuing Education Tian Merren-Owens, ext. 120
Continuing Education Coordinator Stacey Brooks, ext. 210 Coordinator of Membership Christopher Heil, ext. 110
FLORIDA PHARMACY TODAY BOARD Chair............................... Carol Motycka, St. Augustine Vice Chair.........................Cristina Medina, Hollywood Treasurer.................................... Eric Jakab, Gainesville Secretary............................. Julie Burger, Pensacola Member.........................Michael Finnick, Jacksonville Member.............David Mackarey, Boynton Beach Member....................................... Matt Schneller, Tampa Member............................Teresa Tomerlin, Rockledge Member...................................... Greta Pelegrin, Hialeah Technician Member..........Julie Burger, Pensacola Executive Editor.......Michael Jackson, Tallahassee Managing Editor...................Dave Fiore, Tallahassee Journal Reviewer........................... Dr. Melissa Ruble Journal Reviewer....................................Dr. Angela Hill This is a peer-reviewed publication. . ©2021 FLORIDA PHARMACY JOURNAL, INC. ARTICLE ACCEPTANCE: The Florida Pharmacy Today is a publication that welcomes articles that have a direct pertinence to the current practice of pharmacy. All articles are subject to review by the Publication Review Committee, editors and other outside referees. Submitted articles are received with the understanding that they are not being considered by another publication. All articles become the property of the Florida Pharmacy Today and may not be published without written permission from both the author and the Florida Pharmacy Today. The Florida Pharmacy Association assumes no responsibility for the statements and opinions made by the authors to the Florida Pharmacy Today. The Journal of the Florida Pharmacy Association does not accept for publication articles or letters concerning religion, politics or any other subject the editors/publishers deem unsuitable for the readership of this journal. In addition, The Journal does not accept advertising material from persons who are running for office in the association. The editors reserve the right to edit all materials submitted for publication. Letters and materials submitted for consideration for publication may be subject to review by the Editorial Review Board.
FLORIDA PHARMACY ASSOCIATION
610 N. Adams St. • Tallahassee, FL 32301 850/222-2400 • FAX 850/561-6758 Web address: www.floridapharmacy.org.
CALL FOR RESOLUTIONS TO THE 2021 HOUSE OF DELEGATES The House of Delegates Board of Directors will meet in May 2021 to review and approve resolutions for the Annual Meeting. The deadline for submitting resolutions is May 9, 2021! PLEASE NOTE THIS DEADLINE. The last day to submit items of new business is June 8, 2021. The following information will be needed when submitting resolutions: 1. Name of organization: The name of the organization submitting the resolutions(s); 2. Name and telephone number of individuals: A contact in the event clarification or further information is needed; 3. Problem: A statement of the problem addressed by the resolution; 4. Intent: A statement of what passage of the resolution will accomplish; 5. Resolution Format: Please type and use double spacing. TITLE OF RESOLUTION NAME OF ORGANIZATION WHEREAS , AND
WHEREAS :
THEREFORE BE IT RESOLVED (THAT THE FPA OR SUBDIVISION OF FPA)
CONTACT NAME AND PHONE #: PROBLEM: INTENT:
Return this form to: Membership Coordinator, Florida Pharmacy Association, 610 North Adams Street, Tallahassee, Florida 32301 or fax (850) 561-6758
Protect your patients. Protect your pharmacy. ERR ORS C A N I NJ U R E PATIE NTS AND P U T YO UR PHAR M ACY I N F IN AN C IAL J EOPAR DY.
The PQC+ QA program can improve efficiency and increase patient safety as well as help you meet accreditation, credentialing, PBM and state Quality Assurance requirements. • Training, Quality Assurance CE, and resources • Patient Safety Organization protection for your QA work • Practical tools to collect and analyze patient safety data
Learn more at www.medicationsafety.org or call us at (866) 365-7472. The Alliance of Medication Safety (APMS) is a federally listed Patient Safety Organization (PSO).
2021 FPA Legislative Session Update By Michael Jackson, BPharm, CPh, Executive Vice President and CEO The 2020 legislative session is well underway, and as of the release of this issue of Florida Pharmacy Today, we have reached the halfway point. This is a rather unique legislative session driven mostly by the current pandemic. The Capitol complex is essentially sealed from the public with a few exceptions. Testifying before Senate committees is being done from the Donald L. Tucker convention center a few blocks away. Testimony received by House committees are based upon very limited access. The Florida Pharmacy Association’s legislative plan has been presented to the FPA Board of Directors for review and approval. While there is no shortage of issues that we can take to the Legislature, there is a shortage of resources available for our advocacy campaign to be successful. With that we have to prioritize what we are able to do. Our 2021 legislative plan approved by the Board consists of the following: Medicaid Reform ■ Carve-out of pharmacy benefits from the Medicaid Managed Care program ■ Pass-through pricing model ■ Dispensing fee paid to pharmacies Enhancement of Existing PBM Regulations in Florida Statutes and Administrative Codes ■ OIR ability to make rules, impose penalties, levy fines, revoke registration ■ Establish private right of action Reimbursement Transparency in Pharmacy Claims ■ Payment transparency applied to all reimbursement models ■ Require disclosure of reimbursement methodology ■ Establish effective appeals process ■ Prohibit reimbursement below cost benchmarks ■ Prohibit all post-claim fees ■ Prohibit reimbursement disparities for any affiliated pharmacy of insurer Enhancement of Fair Audit Practices Already Existing in Florida Statutes and Administrative Codes ■ Limit number of prescriptions audited and time period of audit ■ Clinical judgements must be done by FL licensed pharmacists ■ Prohibit auditor compensation as percentage of recovery
Network Adequacy Assurance to Allow All Floridians Access to High Quality Pharmacy Services ■ Any willing provider allowed to participate in network ■ Mandatory mail order prohibition ■ Specialty restrictions prohibited – no barrier higher than license Expansion of Protocol-Based Management of Acute Conditions and Chronic Care Management ■ Protocol-based care expanded for acute conditions You can see from the large list above that there is much to be done. As we go to press, we currently see several pharmacy-related issues moving that are tied to our plan. HB1155 and SB390 – Both these bills were designed to enhance the regulatory framework around the way PBMs operate in Florida. You may recall a number of bills passed that inserted the regulation of PBMs under the Board of Pharmacy. It is clear that the Board has no enforcement authority so these bills move that regulation to the Department of Insurance. The original version of these bills were preferred, however through amendments or presentation of committee versions of the bills the scope began to get limited. The Senate version has two more committee stops with the House version needing to make three more committee stops. HB1063, SB898, SB768, SB494, HB459 – With everything going on during the current pandemic and emergency guidance issued by the U.S. Department of Health and Human Services, it was to be expected that bills were going to get filed that address access to vaccine. Various versions of these bills range from either lowering the age of patients to whom a pharmacist can administer vaccines to allowing pharmacy technicians to administer vaccines. Two of these bills have moved through committees in the House, with one already making it to the House floor. The Senate version is making its way through two of three committees. While these bills are supported by the FPA, we are also interested in modifications to make it easier for pharmacists to get an immunization registry without having to submit a physician protocol. We are also interested in amending Florida laws that allows ACPE providers to bring the required 3 hour vaccine administration program to pharmacist licensees. SB928 and HB67 – There are medications on the market used to provide pre-exposure and post-exposure prophylaxis for patients seeking to avoid getting HIV or reducing the risk of HIV due to exposure. Some of these medications are time sensitive, thus the interest in giving pharmacists prescriptive authority. While both of these bills have been filed, they have not moved. See Legislative Update, continued on page 8
8 |
FLORIDA PHARMACY TODAY
Vaccines are coming, but your patients still have questions. Help spread safety messaging by sharing these warnings about vaccine scams on social media. SAFEMEDICINES MEDICINES.org® SAFE MEDICINES .org®
PSM #covidscams
You can find these cards and more at http://safedr.ug/vaccine101
!
FAKE
Scammers sell fake vaccines, vaccines , but your pharmacist or doctor is a safe source.
SAFEMEDICINES SAFE MEDICINES.org® MEDICINES .org®
PSM
#covidscams
COVID vaccines won’t come from Amazon, AliBaba, or non-US pharmacies. Ask your doctor or pharmacist. SAFEMEDICINES SAFE MEDICINES.org® MEDICINES .org®
PSM #covidscams
Keep your patients safe while the vaccine rolls out nationwide.
SAFEMEDICINES.org®
PSM #covidscams
MARCH 2021
|
9
Botulinum Toxin - from Poison to Remedy Clostridium botulinum is a bacterium found in soils. When it encounters an environment that lacks oxygen (anaerobic), such as the human gut, it grows and releases botulinum toxin. The botulinum neurotoxin (BoNT) produces its effects by inhibiting the release of acetylcholine at the nerve endings causing profound paralysis and eventually death through respiratory failure. However, this William Garst, same action when used in appropriate doses Pharm.D. and in localized muscle groups produces reConsultant Pharmacist laxation of muscles. The history of BoNT began in 1735 when an outbreak of botulinum poisoning was recorded in southwest Germany from the consumption of sausages. In 1820, a German medical officer, Justinus Kerner, gave the first clinical description of “sausage poisoning.” He is credited with observing that the toxin was produced under anaerobic conditions and that only a minute amount is needed to produce the paralyzing effects Dr. Kerner was the first to suggest that the toxin could have therapeutic uses. However, it was not until 1895 that the bacteria Clostridium botulinum was identified as the causative organism. The word botulinum is derived from the Latin word for sausage, “botulus.” Botulinum toxin poisoning was a danger in the early days of the canned food industry. Even though canned food was available after the Civil War, it did not become a national industry until the early 1900s. An outbreak of botulism from California canned olives in late 1919 and early 1920 led to the development of stricter production methods and inspections. During World War II the weaponization of botulinum toxin was developed but never used and the Chemical Corps was disbanded. The modern medical use of BoNT began in 1980 when Dr. Alan B. Scott injected the toxin in eye muscles to treat a condition called strabismus, where the eyes do not align properly when looking at an object. In December of 1989, the toxin was
approved by the FDA for strabismus and blepharospasm (abnormal twitching of the eyelid). The use of botulinum toxin was popularized in 2002 when the drug Botox was approved to treat skin wrinkles and frown lines. The clinical use of BoNT is mainly for the treatment of abnormal, excessive, or inappropriate muscle contractions, however, the uses continue to expand and include treatment of a variety of ophthalmologic, gastrointestinal, urologic, orthopedic, dermatologic, dental, secretory, and cosmetic conditions. Only a few of the uses are approved by the FDA; most clinical uses are what is called off-label use, though these are supported by research. Off-label uses are those conditions that are not expressly indicated in a medications package insert. More recently there have been other approved uses of BoNT such as in the treatment of migraine headaches, underarm sweating, and muscle pain. Additionally, research is being conducted using the toxin to treat depression. Other notable instances when toxic substances are used as remedies are Salvarsan (arsphenamine) an arsenic compound used to treat syphilis in the early 1900s. More recently the venom from the Brazilian pit viper was used to develop the class of drugs known as ACE inhibitors used for hypertension. In fact, lisinopril, an ACE inhibitor, is the most prescribed medication in the USA. Stay informed and stay healthy. William Garst is a consultant pharmacist who resides in Alachua, Florida. He received his bachelor’s degree in pharmacy from Auburn University in 1975. He earned a master’s degree in pharmacy from the University of Florida in 2001. In 2007, he received his doctor of pharmacy from the University of Colorado. Dr. Garst is a member of many national professional associations as well as the local Alachua County Association of Pharmacists. He serves on the Alachua County Health Care Advisory Board. He works part-time at the UF Health Psychiatric Hospital and retired from the VA in 2016. Dr. Garst enjoys golf, reading (especially history) and family. He writes a blog called The Pharmacy Newsletter (https://thepharmacynewsletter.com). He can be contacted at
Legislative Update, continued from page 6
SB700 – Legislation related to telehealth has been filed to make revisions to Florida law to recognize telehealth services that are paid for by Medicaid and to clarify the use of telehealth for practitioners, such as but not limited to, APRNs, CRNAs and PAs. Included in this legislation is language that also creates a remote dispensing pharmacy similar to what was introduced a few years ago that was objected to by the Florida Pharmacy Association. The FPA is not in support of that section of the bill but does support the concept of telepharmacy and recognizing the payment for telepharmacy services. 10
|
FLORIDA PHARMACY TODAY
These are just a few of the issues that we have our eyes on for this legislative session. The last day of the 2021 session will be April 30 unless extended. Keep your eyes out for email messaging from the FPA office. A full report of the policies considered by the House and Senate will be available at the FPA annual meeting in Ponte Vedra, Florida, July 7 – 11, 2021.
Former FPA President Theresa Tolle Elected to Lead the American Pharmacists Association Theresa Tolle, B.S. Pharm., FAPhA, a 1988 graduate of the University of Florida College of Pharmacy, has been elected to lead the American Pharmacists Association, or APhA, the largest association of pharmacists in the U.S. She will serve a one-year term as president-elect beginning in 2021, before taking over as APhA president in March 2022. Tolle owns Bay Street Pharmacy in Theresa Tolle, Sebastian. Her independent pharmacy B.S. Pharm., FAPhA focuses on patient services such as counseling, medication therapy management, compounding, durable medical equipment, immunizations and pharmacogenomics testing. She has been active throughout her career in many local, state and national pharmacy associations, including service as president of the Florida Pharmacy Association and Brevard County Pharmacy Association as well as treasurer of the
Onsite State & Federal Regulatory Compliance Consultations Defense of PBM Audits Professional Licensure Disciplinary Proceedings Commercial, Civil Litigation Pharmacy Purchases and Sales
KAHAN & ASSOCIATES, P.L.L.C. PHARMACIST ATTORNEY BUSINESS BROKER
Brian A. Kahan, R.Ph., J.D.
LICENSED Florida Pharmacist and Attorney STAT EW I DE R EPR E SEN TAT ION 561-392-9000 bkahan@kahanlaw.com 7000 W. Palmetto Park Rd., Suite 210 Boca Raton, FL 33433 The hiring of a lawyer is an important decision that should not be based upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience.
Florida Pharmacy Political Action Committee. Tolle has served APhA in several national leadership roles, including committee appointments, Speaker of the House from 2014-17, and she is currently a Trustee. In 2019, the UF College of Pharmacy awarded Tolle its Outstanding Pharmacy Alumnus Award. Other professional awards include the 2018 National Community Pharmacy Association Preceptor of the Year, the Florida Pharmacy Association Bowl of Hygeia in 2012, APhA Fellow and Cardinal Health’s Ken Wurster Community Leadership Award in 2011 and the 2004 APhA Good Government Pharmacist of the Year Award. Tolle becomes the second UF College of Pharmacy graduate to lead APhA in recent years, as Ed Hamilton, Pharm.D., FAPhA, ’75 and ’00, served as APhA president from 2009-10.
Helping independent pharmacies compete since 1982. Now with more services to thrive in today's pharmacy landscape. • New! Exclusive! ERxDirect telemed platform with care management revenue opportunities • New! Consumer engagement model for better outcomes and adherence • Group volume purchasing • Profits distributed to members at year-end • EPIC Pharmacy Network – third party contracting • – claims reconciliation and automated reimbursements below cost system • – regulatory and compliance management
A Network Of Independently Owned Pharmacies 800-965-EPIC (3742) | epicrx.com membersupport@epicrx.com
MARCH 2021 |
11
HIV Treatments Centers for Disease Control and Prevention
Not enough people are getting tested for HIV, the Centers for Disease Control and Prevention says. “The time is now to end HIV in America. We have the right tools, the right data and the right leadership to get this done,” said CDC Director Robert R. Redfield, M.D. “Those living with HIV are our best teachers. They are key to helping us reach people where they are so that we can better diagnose and link patients to care.” A CDC report released in December 2019 shows that increasing HIV testing, treatment and prevention is critical to stopping HIV transmission in the U.S. More than 700,000 Americans have died from HIV since 1981 and more than 1.1 million Americans 12
|
FLORIDA PHARMACY TODAY
are living with HIV. New diagnoses have declined significantly, the CDC says, with about 40,000 Americans being newly diagnosed each year. The agency says, however, that there is a risk of resurgence from drug use and diagnostic complacency among health care providers. A new initiative by the Trump administration, Ending t he HIV Epidemic: A Plan for America, aims to reduce the number of new HIV infections by 75 percent within five years and by 90 percent within 10 years. New Medications Lead the Fight The CDC points to advances in antiretroviral therapies that allow people who take their medicines as
prescribed to maintain an undetectable viral load, living long lives and with little risk of sexually transmitting HIV to a partner. There’s also pre-exposure prophylaxis, a daily regimen of two oral antiretroviral drugs in a single pill, which has proven to be highly effective in preventing HIV infection in populations of high risk. PrEP could help more than a million people in the U.S., the Department of Health and Human Services says, but only around 20 percent of those get a prescription. Most people don’t know about PrEP or can’t afford it, DHHS says. A new program, “Ready, Set, PrEP,” will pay for medications for those who qualify, meaning they test negative for HIV, have a valid prescription from a health care provider and not have insurance that covers prescription drugs. Once in the program, patients can receive PrEP from the pharmacy of their choice. Patients will need to get tested by their health care provider every three months to make sure they don’t have HIV or other conditions. The PrEP medication will be free through the program, but the costs of clinic visits and lab costs may depend on income. Two medications are FDA-approved for use as PrEP, Truvada and Descovy. Each is a single tablet that contains a combination of medications to f ight HIV. Tr uvada is tenofovir disoproxil fumarate and emtricitabine. Descovy is tenofovir alafenamide and emtricitabine. PrEP medications should be used as part of a combination prevention plan that includes regular HIV testing, testing for other sexually transmitted diseases and assessment for side effects from PrEP medication. Counseling for plan adherence, sexual behaviors and condom use should also be considered. Other testing may include hepatitis B and renal testing. Accordi ng to t he CDC, t hese populations may benefit the most from PrEP medications:
■ ■
■ ■
■
■
A gay/bisexual man with an HIVpositive partner. A gay/bisexual man with multiple partners, a partner with multiple partners, or a partner whose HIV status is unknown, and you have sex without a condom or have recently had a sexually transmitted disease. A heterosexual person who has an HIV-positive partner. A heterosexual person who has multiple partners, a partner with multiple partners or a partner whose HIV status is unknown and who also doesn’t always use a condom for sex with people who inject drugs or who doesn’t always use a condom for sex with bisexual men. A person who injects drugs and shares needles, syringes or other equipment. A person who injects drugs and is at risk for getting HIV from sex.
Despite the advances in health care, the CDC says that too few people are getting the care they need for HIV. About 40 percent of infections in 2016 came from people who didn’t know they had HIV. Another 60 percent came from people who knew they had HIV but were not getting care or taking medicine consistently. The agency wants health care providers to test all their patients, regardless of risk, at least once in their lives. Highrisk populations should be tested at least once a year, with some as much as once every six months. HIV treatment should be initiated as soon as possible after diagnosis, and PrEP medications should be prescribed to all who could benefit from it.
age 65, with those ages adjusted if patients have risk factors for HIV infection, especially if those patients have new sex partners. The task force says most new diagnoses of HIV infection are attributed to male-tomale sexual contact. Injection drug use is another important factor, it says. Additional risk factors include sex without a condom, having more than one sexual partner, engaging in transactional sex, having other sexually transmitted infections or a sex partner with sexually transmitted infections. Providers should remember that patients may be reluctant to disclose risk factors.
Screening Recommendations The U.S. Preventive Services Task Force issued new recommendations for HIV testing in 2019. It recommends testing begin at age 15 and run through
JOIN TODAY!
MARCH 2021
|
13
SAVE THE DATE! 131st ANNUAL MEETING AND CONVENTION July 7 – 11, 2021
You don’t want to miss this event! General Education Track Consultant Education Track Student & Technician Track Social Distanced Special Events Exhibits • Receptions • Awards
Sawgrass Marriott Golf Resort & Spa Ponte Vedra Beach, FL
Room reservations can be made by calling (888) 821-1364. Room Rates: $179 plus tax based on single/double occupancy. The room reservation deadline is Friday, June 11, 2021 or when room block is full. Thereafter, reservations may be taken on a space available or rate available basis. There is an optional resort fee. Self-parking is discounted to $10 per day. Please be sure to ask for the Florida Pharmacy Association group rate. All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card. The check-in time is 4:00pm and the checkout time is 11:00 am. 14
|
FLORIDA PHARMACY TODAY
1
FPA 131st Annual Meeting and Convention July 7-11, 2021 Ponte Vedra Beach, FL
,
55Daily Education Registration
Participant Information Participant Information
Daily registration does not include admittance to functions or handbooks. Handouts will be posted on our website July 6.
Name: _____________________________________________________ Name _______________________________________________ Address______________________________________________ Badge Name: _______________________________________________ City, State, Zip_________________________________________ Mailing Address: ____________________________________________ Phone___ ________________________ City, State, Zip: _____________________________________________ Email________________________________________________ Phone: (W) (H)_______________________ Practice Setting________________________________________ License: PS______________ PU _____________RPT_________ Fax: ______________________________________________________ NABP Date of Birth___________ License:e-profile#__________________ PS________________ PU_________ Other State________ Emergency Contact Name/Number_________________________
2
Before
June 18
Onsite
Amount
FPA Member
$165
$185
$_______
Non Member
$215
$235
$_______
Member Technician
$65
$85
$_______
Non Member Technician
$90
$110
$_______
Handbooks
$40
$40
$_______
Please select the day(s) you will attend: Thursday
Full Package Registration
Full package registration includes Educational Programs Thursday-Sunday, House of Delegates on Thursday, Exhibit Hall Friday and Saturday, Receptions, and Awards Event on Saturday. Handbooks are not included in full package registration. Handouts will be available the week of the convention on our website, www.floridapharmacy.org. Onsite
Amount_
6
Friday
Saturday
Sunday
Additional Tickets
The following events are included in the Full Registration Package, if requested. However, you must purchase additional tickets for guests who are NOT registered. Quantity
Price
Amount
Exhibit Hall
$30
$______
Awards Event
$80
$______
2FPA Member
Before June 18 $345
$430
$_______
Non Member
$525
$610
$_______
Pharmacist BEST Value
$540
$625
$_______
Member Technician
$155
$185
$_______
Non Member Technician
$175
$210
$_______
Technician BEST Value
$185
$220
$_______
$150
$170
$_______
Poster Presenter
$40
$40
$_______
(Registration fee is based upon membership and professional status for Non-convention registrants.)
3Student
Handbooks
(BEST Value includes Registration & Membership)
3
House of Delegates (Thursday)
FPPC Reception (Thursday)
Exhibit Hall (Friday and/or Saturday)
Awards Event (Saturday)
Christian Fellowship (Sunday)
I will not attend any of these functions.
4
House of Delegates
House of Delegates (Non-convention registrants)
Special Events Registration
The Poster Event is available to all pharmacy professionals and included in full and daily registrations. The Student Awards Event is not included in any registration packages. Quantity
8
_______
Amount $______
$50
$______
FPA Polo Shirt (Deadline is June 4) Quantity Price
9
Price
One Day Registration
Student Awards Event
Please indicate below which functions you will attend. If no boxes are selected, we will assume you will not attend any of the events listed below. Please see box 6 for additional tickets.
7
Yes
______
Payment
$35
M/F ______
Size ______
Amount $_______
Total Enclosed: $______
Check (To: FPA) AMEX Discover MasterCard Visa Account # ____________________________________________ Security Code _________________ Expiration Date __________
Before June 8 $165
Amount ______
Billing Address ________________________________________ Signature ____________________________________________
Four Ways to Register
Mail: FPA, 610 North Adams Street, Tallahassee, FL 32301 Phone: 850-222-2400 Fax: 850-561-6758 Web: www.floridapharmacy.org
Schedule and Fee Subject to Change
MARCH 2021
|
15
Sponsorship Levels PLATINUM ($10,000+)
• Free Exhibitor Table at both shows • Three complimentary passes for one day of Continuing Education • One complimentary hotel accommodation at Convention • Recognition in Convention Journal • Two complimentary reserved seating banquet tickets upon request • Company name on sponsorship sign • Full page ad in Gatherin’ Packet • Platinum sponsor ribbon • Exclusive sponsorship of an available FPA event • Recognition on FPA website for 6 months upon request
GOLD
($7,500-$9,999) • Free Exhibitor Table • Two complimentary passes for one day of Continuing Education • Recognition in Convention Journal • One complimentary reserved seating banquet ticket upon request • Company name on sponsorship sign • Gold sponsor ribbon • Recognition on FPA website for 3 months upon request • Exclusive sponsorship of an available FPA event
Why Exhibit
For more information, visit www.floridapharmacy.org or call (850) 222-2400
SILVER ($5,000-$7,499)
• One complimentary pass for one day of Continuing Education • Recognition in Convention Journal • Company name on sponsorship sign • Silver sponsor ribbon • Recognition on FPA website for 1 month upon request • Support of an available FPA event
Exhibitor Set Up Exhibits Open
Exhibitor Move Out
16
|
Friday, July 9 Friday, July 9 Saturday, July 10 Saturday, July 10
FLORIDA PHARMACY TODAY
7 AM to 11 AM 11 AM to 1 PM 11 AM to 1 PM 1 PM to 5 PM
T b c h A
T v th in r w ta
T G c y
• Network with pharmacists of various practice settings, pharmacy technicians, pharmacy students and other pharmacy professionals. • Showcase and demonstrate the value of your products and services to attendees face-to-face • Recruit new pharmacists, pharmacy technicians, and new practitioners • Introduce a new product or service • Build brand awareness • Strengthen existing and establish new client relationships • Network, network, network!
Sponsors will be listed in convention schedules, the signage at the convention, and in the monthly publication of Florida Pharmacy Today. However, there are printing deadlines that must be met for each. Please contact the FPA office if you are interested in providing sponsorship for the 131st Annual Meeting and Convention or the 38th Annual Southeastern Gatherin’. Partial sponsorship is available, (850) 222-2400, ext. 120 or email tmerren@pharmview.com.
EXHIBIT TIMES for 131st ANNUAL CONVENTION
R
EXHIBIT TIMES for 38th ANNUAL GATHERIN’
Exhibitor Set Up Exhibits Open
Sunday, August 1 Sunday, August 1
Exhibitor Move Out
Monday, August 2 Tuesday, August 3 Tuesday, August 3
12 PM to 3 PM 3 PM to 4 PM 6 PM to 7 PM 7 AM to 8 AM 7 AM to 8 AM 8 AM to 12 Noon
E 3 a c th C th C 3 fo th b A S c c b a a Q a
F b e
24/7 coverage lets you focus on patients, not potential mistakes.
PROFESSIONAL LIABILITY COVERAGE COMPARISON PHARMACIST MUTUAL INSURANCE COMPANY
COMPETITOR
Pharmacists Professional Liability
$1MM per occurrence / $3MM aggregate $2MM per occurrence / $4MM aggregate
$1MM per occurrence / $3MM aggregate
Sterile Compounding
Available
?
Pharmacists License Defense Coverage
$250,000 per occurrence / $250,000 aggregate
$25,000
Board of Pharmacy Imposed Fees
$2,500 sublimit
?
HIPAA Claim Defense Coverage
$50,000
$25,000
Assault Coverage
$25,000
$25,000
Sexual and Physical Abuse Coverage
$50,000
$25,000 sublimit
$1,500 per day / $50,000 per occurrence
1,000 per day / $25,000 aggregate
$50,000 limit
$10,000 aggregate
Loss of Income Legal fees – Respond to Subpoena
Professional | Commercial | Personal | Life & Disability
phmic.com Policy terms and conditions control. Coverage may not be available in all states. Life and disability insurance are written through PMC Advantage Insurance Services, Inc., a wholly-owned subsidiary of Pharmacists Mutual Insurance Company.
WHAT IF you were named in a lawsuit and needed a lawyer?
WHAT IF your employer does not have the coverage to protect you?
WHAT IF you have a second job, volunteer, or give advice to a friend or neighbor? MARCH 2021
|
17
New Data Show Decline in Drug Overdose Deaths From the Centers for Disease Control and Prevention
From 2017-2018, overall overdose death rates decreased by 4.1 percent. Death rates involving heroin dropped by 4 percent and prescription opioid overdose deaths decreased by 13.5 percent. “Decreases in overdose deaths involving prescription opioids and heroin reflect the effectiveness of public health efforts to protect Americans and their families,” said CDC Director Robert R. Redfield, M.D. “While we continue work to improve those outcomes, we are also addressing the increase in overdose deaths involving synthetic opioids. We must bring this epidemic to an end.” The bad news: Death rates involving synthetic opioids – excluding methadone – increased by 10 percent in the same period. These numbers from a CDC analysis of the latest available drug overdose death data from the Morbidity and Mortality Weekly Report, which analyzes changes in age-adjusted overdose death rates by demographic characteristics, county urbanization levels, U.S. Census region and state. From 19992018, more than 750,000 Americans died from drug overdoses. “To sustain decreases and continue to prevent and respond to drug over18
|
FLORIDA PHARMACY TODAY
doses, specifically those involving synthetic opioids, it is critical to have a coordinated response,” said Debra Houry, M.D., M.P.H., director of CDC’s National Center for Injury Prevention and Control. “Medical personnel, emergency departments, public health and public safety officials, substance abuse treatment providers, community-based organizations, and members of the community all play a role in addressing this complex and fast-moving epidemic.” Synthetic Opioid Deaths Synthetic opioids were involved in 31,335 overdose deaths, nearly half of all overdose deaths in 2018. This is likely due to the illicitly manufactured fentanyl. The four states with the highest increases were Arizona, California, Washington and Missouri. “Opioid overdoses decreased from 2017 to 2018 but still remain high. Efforts must be strengthened to maintain and accelerate decreases in deaths involving prescription opioids and heroin and to prevent continued increases in overdose deaths involving synthetic opioids,” said Nana Wilson, Ph.D., epidemiologist at CDC and lead author of this MMWR study.
An Evolving Crisis Efforts to improve opioid prescribing practices have increased and may have contributed to decreases in prescription opioid-involved overdose deaths. Drops in heroin-involved deaths may be attributable to reductions in the number of people initiating heroin use and shifts from a heroin-based market to a fentanyl-based market, as well as increased treatment for people using heroin and more access to naloxone. CDC continues to work closely with other federal agencies to support the U.S. Department of Health and Human Services’ Five-point Strategy to prevent and respond to drug overdoses, specifically those involving opioids. The strategy provides better treatment, better data, better research, increased access to naloxone and better pain management. CDC is working with states, territories, and cities and counties across the country to continue surveillance and prevention efforts. These efforts are to help inform and to sustain decreases and prevent continued increases through Overdose Data to Action, a three-year cooperative agreement through which CDC funds health departments in 47 states, Washington, D.C., two territories, and 16 cities and counties for surveillance and prevention efforts. This report also reinforces the continued need for response strategies, including expanding the distribution of naloxone for overdose reversal, increasing the provision of medication-assisted treatment, enhancing public health and public safety partnerships, and enhancing linkage to treatment and harm reduction services. A comprehensive, multisectoral surveillance, prevention, and response approach remains critical for sustaining and expanding preliminary successes in reducing opioid-involved overdose deaths.
CALL FOR ABSTRACTS FOR POSTER PRESENTATIONS FLORIDA PHARMACY ASSOCIATION 131st ANNUAL MEETING AND CONVENTION
July 7-11, 2021 Sawgrass Marriott Golf Resort ♦ Ponte Vedra Beach, Florida Poster Session: Friday, July 9, 2021 ♦ 11:00AM-1:00PM COST $ONE DAY REGISTRATION The FPA Poster Presentations are open to PHARMACISTS, RESIDENTS, STUDENTS, AND TECHNICIANS. Complete and submit this COVERSHEET for each abstract submission. Submissions must be received no later than Friday, May 7, 2021. Abstracts will NOT be accepted after this date. Mail or E-mail this application along with the abstract submission to:
PLEASE TYPE
Tian Merren Owens, MS, PharmD, Director of Continuing Education Florida Pharmacy Association 610 N. Adams Street Tallahassee, FL 32301 tmerren@pharmview.com
Contact Information: Presenter's Name: _______________________________________________________________________________ □ Pharmacist
□ Resident
□Student
□ Technician
Address: ________________________________________________________________________________________ City, State, Zip: ___________________________________________________________________________________ Telephone No: _____________________E-Mail Address: _________________________________________________ College of Pharmacy: _____________________________________________________________________________ Abstract Title: ____________________________________________________________________________________ Poster Type:
□ Basic Science Research □ Best Practice □ Clinical Research □ Literature Review □ Translational Research (Basic Science and Clinical Research)
Primary Author: __________________________________________________________________________________ (Presenter will be notified by mail of acceptance). Co-Author(s): ____________________________________________________________________________________ Awards:
Posters will be eligible for 1st, 2nd, and 3rd place prizes to be presented at Convention. (Only one prize is given for each winning poster)
ABSTRACT FORMAT The abstract form submitted should be the equivalent of one page. The abstract should include: Title (Include authors’ names and name of College of Pharmacy), Purpose, Methods, Results, and Conclusions. Abstracts will not be accepted if it is not in this format. Do not include figures or graphs.
Please direct all questions and concerns to: Tian Merren Owens ♦ (850) 222-2400 ext. 120 ♦ tmerren@pharmview.com DEADLINE DATE: FRIDAY, MAY 7, 2021 MARCH 2021
|
19
“I’M ALWAYS WATCHING OUT FOR MY PATIENTS, BUT WHO’S WATCHING OUT FOR ME?”
WE ARE. We are the Alliance for Patient Medication Safety (APMS), a federally listed Patient Safety Organization. Our Pharmacy Quality Commitment (PQC) program: • • • •
Helps you implement and maintain a continuous quality improvement program Offers federal protection for your patient safety data and your quality improvement work Assists with quality assurance requirements found in network contracts, Medicare Part D, and state regulations Provides tools, training and support to keep your pharmacy running efficiently and your patients safe
Call toll free (866) 365-7472 or visit www.pqc.net PQC IS BROUGHT TO YOU BY YOUR STATE PHARMACY ASSOCIATION
